Resources

Innovative closed process CAR-T cell therapy platform to streamline approach for manufacturing with great predictability

– The development of innovative advanced therapies represents a great opportunity to dramatically improve patients’ lives.  However, the rapid and efficient production of these advanced therapies remains a considerable challenge. – Recent technological advancements in the process development of CAR-T cell therapy manufacturing. – A modular approach was used to optimize unit operations to build …Read More >

Resource Type: Poster
Resource Topic:

VIEW

WuXi Advanced Therapies has added Mycoplasma Real-Time PCR Detection (MycoSEQ™) to our menu of innovative solutions

WuXi Advanced Therapies has added Mycoplasma Real-Time PCR Detection (MycoSEQ™) to our menu of innovative solutions! This assay method can be used for lot release by drugmakers of biotherapeutics, cell therapy products, biologics, and vaccines to detects more than 90 mycoplasma species with high specificity and no cross-reactivity to closely-related bacterial species rapidly and reliably. …Read More >

Resource Type: Publication
Resource Topic: Advanced Testing

VIEW

Innovative Closed Process CAR-T cell therapy platform to streamline approach for manufacturing with great predictability

Date: May 19, 2020 Time: 11 am EDT | 8 am PDT | 5 pm CEST For many years, the primary forms of cancer treatment have been chemotherapy, radiation, and surgery. An amazing breakthrough known as chimeric antigen receptor (CAR) T-cell therapy is being studied in the treatment of various types of cancer, including acute and …Read More >

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing

VIEW

World-class AAV vector suspension platform to accelerate commercialization to market with greater predictability

WuXi Advanced Therapies launched a new world-class adenoassociated virus (AAV) vector suspension platform that complements integrated capabilities enabling cell and gene therapies to be developed, manufactured, and released faster and with greater predictability globally.

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Interview: Accelerating advanced therapy pipelines and viral vector commercialisation

  In January, Phacilitate Leaders World & World Stem Cell Summit 2020 brought together the entire ecosystem of the advanced therapies industry from all corners of the globe to continue to build strong partnerships and collaborations to Miami, FL.  Phacilitate team spoke to Felix Hsu, Senior Vice President and Global Head at WuXi Advanced Therapies about strategically looking …Read More >

Resource Type: Article
Resource Topic: Clinical & Commercial Manufacturing

VIEW